Currently still bid at 142.80 but 143.00 the next hurdle to leap
Sellers 143.00 142.20 143.30 143.50
Buyers 142.50 142.20 142.00 141.80 14150
Currently still bid at 142.80 but 143.00 the next hurdle to leap
Sellers 143.00 142.20 143.30 143.50
Buyers 142.50 142.20 142.00 141.80 14150
Most Popular
Sponsored
Biogen buys Apellis for $5.3B, adding $689M revenue drugs. Potential $4 CVRs tied to SYFOVRE sales.
Dutch Bros (3.3x P/S) & e.l.f. Beauty (15.5x P/E) offer growth at bargain valuations. MELI's 49% revenue jump at 24.5x P/E.
SHC beats revenue estimates on pricing & demand, but market reacts negatively. Watch margins!
Ackman buys MSFT at 21x forward earnings, seeing value despite AI & Azure concerns. Stock down 17% YTD.
BAE Systems' APKWS rockets surge in price amid high demand; expect boosted profit margins.
Aluminum prices surge 4-yr high, impacting Diet Coke cans & packaging. CO2, fertilizer shortages loom.
RVTY beats EPS, margins soar 39% on strong execution, but revenue guidance drops 5%. Buy?
Sponsored
Must Read